GMO US Value ETF
GMOV
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- GMO U.S. Value ETF (GMOV) is an actively managed exchange-traded fund that seeks total return by investing primarily in U.S. equity securities identified as undervalued using proprietary quantitative methods from GMO's Asset Allocation and Systematic Equity teams; the fund targets "deep value" stocks in the cheapest 20% of the U.S. market, avoiding "shallow value" names that appear expensive relative to their historical valuations, to capitalize on market dislocations. Launched on October 28, 2024, and listed on NYSE Arca, the ETF employs a top-down valuation approach combined with bottom-up stock selection, focusing on U.S. companies across market capitalizations with the most attractive valuations as determined by GMO's disciplined, long-term processes. The fund holds approximately 187 securities, maintains assets under management of around $53 million, and charges a net expense ratio of 0.50%. Grantham, Mayo, Van Otterloo & Co. LLC (GMO), the investment adviser headquartered in Boston, Massachusetts, and founded in 1977, manages the ETF through its Systematic Equity Team led by George Sakoulis, with portfolio managers Warren Chiang, Tara Oliver, and John Thorndike. GMO, a privately owned global asset manager with approximately $70 billion in assets under management as of September 30, 2024, operates offices in Boston, London, Sydney, Amsterdam, Singapore, and a representative office in Tokyo, serving institutional investors, financial intermediaries, and high-net-worth families focused on valuation-driven strategies. The ETF is part of GMO ETF Trust and distributed by Foreside Fund Services LLC. In October 2024, GMO launched GMOV alongside two companion ETFs—GMO International Quality ETF (QLTI) and GMO International Value ETF (GMOI)—as part of an expansion of its ETF lineup building on the success of its inaugural ETF, GMO U.S. Quality ETF (QLTY), which exceeded $1 billion in assets shortly after its November 2023 debut. This launch was supported by the Goldman Sachs ETF Accelerator platform to enable efficient listing and management. GMO has also filed for additional ETFs, including GMO Beyond China (BCHI) and GMO Systematic Investment Grade Credit (INVG), signaling further strategic growth in its actively managed ETF offerings as of late 2024. As of September 30, 2025, the fund continues to emphasize its opportunistic deep value focus amid ongoing U.S. equity market dynamics.